Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for complement C3b (compound)
Most Correlated Studies
- Polymorphonuclear leukocytes (PMNs) and PBMCs of Job's patients incubated with IgG and C3bi beads
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- A bifunctional amylopullulanase of Streptococcus suis ApuA contributes to immune evasion by interact…
- Purified complement C3b triggers phagocytosis and activation of human neutrophils via complement rec…
- HylS', a fragment of truncated hyaluronidase of Streptococcus suis, contributes to immune evasion by…
- Trypanosoma brucei Invariant Surface gp65 Inhibits the Alternative Pathway of Complement by Accelera…
- Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags.
Most Relevant Clinical Trials
- First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers
- Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor T…
- Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury
- Erythrocyte Complement Receptor 1 and Alzheimer Disease
- Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris
